Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11925764 Nitric oxide therapies

Patent 11925764 was granted and assigned to Vero Biotech on March, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

David H. Fine0

Date of Patent

March 12, 2024

0

Patent Application Number

174614840

Date Filed

August 30, 2021

0

Patent Citations

US Patent 7045106 Method for producing inorganic porous material

0

US Patent 7147011 Method for packing solid catalyst

0

US Patent 7160366 Filter element

0

US Patent 7166139 Compact steam reformer

0

US Patent 7282519 Nitrosated and nitrosylated diuretic compounds, compositions and methods of use

0

US Patent 7288664 Reverse Kleiner method for manufacturing nitrogen dioxide, nitric oxide, nitric acid, metallic ascorbates and alkyl ascorbates of vitamin C

0

US Patent 7335181 Nitric oxide decontamination of the upper respiratory tract

0

US Patent 7407632 Apparatus and delivery of medically pure oxygen

0

...

Patent Primary Examiner

0

CPC Code

0

0

0

0

0

0

0

0

...

Patent abstract

A method for delivering nitric oxide therapy to a subject can include administering a composition including a nitric-oxide releasing agent and silica to the subject and releasing a therapeutic amount of nitric oxide from the composition.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11925764 Nitric oxide therapies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool